TSWM
TEVA icon

Tyler-Stone Wealth Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Tyler-Stone Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-72
Closed -$1.17K – 879
2024
Q2 		$1.17K Hold
72
– – ﹤0.01% 898
2024
Q1 		$1.02K Hold
72
– – ﹤0.01% 896
2023
Q4 		$752 Hold
72
– – ﹤0.01% 883
2023
Q3 		$1K Hold
72
– – ﹤0.01% 889
2023
Q2 		$1K Buy
+72
New +$584 ﹤0.01% 871
2022
Q4 		$2K Hold
272
– – ﹤0.01% 770
2022
Q3 		$2K Hold
272
– – ﹤0.01% 767
2022
Q2 		$2K Hold
272
– – ﹤0.01% 777
2022
Q1 		$3K Hold
272
– – ﹤0.01% 734
2021
Q4 		$2K Buy
+272
New +$2.46K ﹤0.01% 818

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Tyler-Stone Wealth Management's TEVA Position: Q3 2024 in Review

Tyler-Stone Wealth Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2024, closing a stake of 72 shares — an estimated $1.17K sold.

Tyler-Stone Wealth Management first reported a position in TEVA in Q4 2021 and held it in 10 quarters. The position peaked at $3K in Q1 2022. 543 funds tracked by Wall St. Rank hold TEVA as of Q3 2024.

  • Tyler-Stone Wealth Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2024 after selling out during the quarter.
  • Tyler-Stone Wealth Management sold 72 Teva Pharmaceutical Industries Limited shares in Q3 2024, an estimated $1.17K.
  • Tyler-Stone Wealth Management first reported a position in Teva Pharmaceutical Industries Limited in Q4 2021 and held it in 10 quarters.
  • Tyler-Stone Wealth Management's Teva Pharmaceutical Industries Limited position peaked at $3K in Q1 2022.
  • 543 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2024.

Based on Tyler-Stone Wealth Management's 13F filing for Q3 2024, filed 4 Nov 2024.